List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 41 studies with search of: Open Studies | "Conjunctivitis"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Condition: Adenoviral Conjunctivitis
Interventions: Drug: AL-46383A Ophthalmic Solution;   Drug: AL-46383A Vehicle
2 Not yet recruiting Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Besifloxacin;   Drug: Vehicle (Placebo)
3 Recruiting Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
4 Recruiting Acute Adenoviral Conjunctivitis
Condition: Acute Adenoviral Conjunctivitis
Interventions: Drug: 0.4% PVP-I/0.1% Dexamethasone;   Drug: Placebo
5 Recruiting Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis
Conditions: Blepharitis;   Conjunctivitis;   Keratitis
Interventions: Drug: Moxifloxacin and Dexamethasone combined;   Drug: Moxifloxacin;   Drug: Dexamethasone
6 Recruiting Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Moxifloxacin eye drops;   Drug: Moxifloxicin AF Ophthalmic Solution Vehicle (placebo)
7 Not yet recruiting AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
Condition: Allergic Conjunctivitis Associated Inflammation
Interventions: Drug: AL-38583 Ophthalmic Solution;   Drug: AL-38583 Ophthalmic Solution Vehicle;   Drug: Dexamethasone Ophthalmic Suspension
8 Not yet recruiting Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.
Condition: Allergic Conjunctivitis
Interventions: Drug: Ketotifen/naphazoline;   Drug: Ketotifen/naphazoline and Vehicle;   Drug: Ketotifen/naphazoline and Naphazoline;   Drug: Ketotifen/naphazoline and Ketotifen;   Drug: Ketotifen and Ketotifen/naphazoline;   Drug: Ketotifen and Vehicle;   Drug: Ketotifen and Naphazoline;   Drug: Ketotifen;   Drug: Naphazoline and Ketotifen/naphazoline;   Drug: Naphazoline and Vehicle;   Drug: Naphazoline;   Drug: Naphazoline and Ketotifen;   Drug: Vehicle and Ketotifen/naphazoline;   Drug: Vehicle;   Drug: Vehicle and Naphazoline;   Drug: Vehicle and Ketotifen
9 Not yet recruiting An Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234AM1)
Conditions: Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: 1.5 Amb a 1-U;   Biological: 6 Amb a 1-U;   Biological: 12 Amb a 1-U;   Biological: Placebo
10 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
11 Recruiting Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
Condition: Atopic Conjunctivitis
Interventions: Drug: Cyclosporine Vehicle;   Drug: Cyclosporine 0.010%;   Drug: Open-labeled Cyclosporine 0.010%
12 Not yet recruiting Comparison of CL Wear Between Two Allergy Drops
Condition: Allergic Conjunctivitis
Intervention: Drug: epinastine HCL and olopatadine HCL
13 Not yet recruiting An Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)
Conditions: Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: 6 Amb a 1-U;   Biological: 12 Amb a 1-U;   Biological: Placebo
14 Not yet recruiting Standardization of Glycyphagus Domesticus Allergenic Extract
Conditions: Rhinitis, Allergic;   Seasonal Conjunctivitis, Allergic
Intervention: Other: Standardization of allergenic extract (Glycyphagus domesticus)
15 Not yet recruiting Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
Condition: Allergic Conjunctivitis to Tree Pollen or Grass Pollen
Interventions: Drug: Fluticasone furoate nasal spray;   Drug: Placebo nasal spray
16 Not yet recruiting Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
Conditions: Rhinoconjunctivitis;   Rhinitis;   Conjunctivitis;   Allergy
Interventions: Biological: Placebo;   Biological: SCH 39641
17 Recruiting Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients
Conditions: Rhinitis;   Conjunctivitis;   Asthma
Intervention: Biological: subcutaneous immunotherapy
18 Recruiting Allergic Eye Disease Tear Mediators
Condition: Allergic Eye Disease
Intervention: Drug: olopatadine
19 Recruiting Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC)
Condition: Allergic Rhinoconjunctivitis
Intervention:
20 Recruiting Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients
Conditions: Allergic Rhinitis;   Allergic Rhinoconjunctivitis
Intervention: Drug: PURETHAL Mites 20,000 AUeq/ml

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services